Condition
Primary Valvular Heart Disease With Comorbid Coronary Artery Disease
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Qfrguided Strategy
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Active Not Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Qfrguided Strategy1
- Cagguided Strategy1
Active Sponsors
- Ruijin Hospital1
- Med-X Research Institute, Shanghai Jiao Tong University1
Top Investigators
Med-X Research Institute, Shanghai Jiao Tong University
Ruijin Hospital
Weill Medical College of Cornell University
Ruijin Hospital
Related Conditions
- Planned To Undergo Elective Onpump Valve Surgery Due To Primary Mitral Andor Aortic Valvular Heart Disease1